More
    Guided Solutions - Connecting Talent With Innovation/div>

    Protaryx Medical completes first-in-human trial of transseptal puncture device

    US-based Protaryx Medical has completed a first-in-human trial of its transseptal puncture (TSP) device. The company’s trial enrolled five patients, with the TSP procedure carried...

    EndoQuest wins FDA IDE to study surgical robot in colorectal surgery

    EndoQuest Robotics announced it received FDA investigational device exemption (IDE) for a study of its surgical robot. The IDE allows the Houston, Texas-based company...

    ShiraTronics initiates FDA IDE study for implantable neuromod

    ShiraTronics announced it initiated its FDA investigational device exemption (IDE) pivotal trial for its neuromodulation therapy. The RELIEV-CM2 clinical study evaluates the company’s neuromodulation...

    Nervonik completes first human study of nerve stim tech for chronic pain

    Nervonik announced it completed the first-in-human clinical study of its peripheral nerve stimulation (PNS) device. The Los Angeles-based startup designed its proprietary device to enhance...

    Orthocell completes FDA 510(k) regulatory study for Remplir™

    The regulatory study validated Remplir as a safe and effective biological medical device for use in the surgical repair of peripheral nerves and will...

    BrioHealth begins enrolment in LVAD study for its BrioVAD system

    BrioHealth Solutions enroled its first patients in the U.S. for the INNOVATE trial of its BrioVAD system. Burlington, Massachusetts–based BrioHealth has had its BrioVAD...

    EmStop completes trial of embolic protection system

    EmStop has completed the ‘Controlled Arterial Protection to Ultimately Remove Embolic Material’ (CAPTURE-1) early feasibility clinical study which assessed the EmStop embolic protection system. The...

    Supira begins early feasibility study for percutaneous ventricular assist device

    Supira Medical began patient enrolment in a U.S. early feasibility trial of its percutaneous ventricular assist device (pVAD). The Shifamed portfolio company plans to evaluate...

    EndoTheia completes first-in-human study of steerable kidney stone basket

    EndoTheia completed the first-in-human clinical trial for its FlexStone basket, a steerable kidney stone treatment. Nashville, Tennessee-based EndoTheia said its FlexStone basket represents the...

    Latest articles